Renal cell carcinoma

被引：112
作者：
Curti, BD [1 ]
机构：
[1] Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Portland, OR 97213 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 01期
关键词：
D O I：
10.1001/jama.292.1.97
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：97 / 100
页数：4
相关论文
共 29 条
[1]  
[Anonymous], COMPREHENSIVE TXB GE
[2]   Metastatic renal carcinoma comprehensive prognostic system [J].
Atzpodien, J ;
Royston, P ;
Wandert, T ;
Reitz, M .
BRITISH JOURNAL OF CANCER, 2003, 88 (03) :348-353
[3]  
Bui MHT, 2003, CLIN CANCER RES, V9, P802
[4]   Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation [J].
Childs, R ;
Chernoff, A ;
Contentin, N ;
Bahceci, E ;
Schrump, D ;
Leitman, S ;
Read, EJ ;
Tisdale, J ;
Dunbar, C ;
Linehan, WM ;
Young, NS ;
Barrett, AJ ;
Clave, E ;
Epperson, D ;
Mayo, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (11) :750-758
[5]   Rising incidence of renal cell cancer in the United States [J].
Chow, WH ;
Devesa, SS ;
Warren, JL ;
Fraumeni, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1628-1631
[6]   Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine [J].
Cohen, L ;
de Moor, C ;
Parker, PA ;
Amato, RJ .
UROLOGIC ONCOLOGY, 2002, 7 (03) :119-124
[7]  
DODERLEIN A, 1894, SEX ORGANE, V3, P88
[8]   A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma [J].
Fenton, RG ;
Steis, RG ;
Madara, K ;
Zea, AH ;
Ochoa, AC ;
Janik, JE ;
Smith, JW ;
Gause, BL ;
Sharfman, WH ;
Urba, WJ ;
Hanna, MG ;
DeJager, RL ;
Coyne, MX ;
Crouch, RD ;
Gray, P ;
Beveridge, J ;
Creekmore, SP ;
Holmlund, J ;
Curti, BD ;
Sznol, M ;
Longo, DL .
JOURNAL OF IMMUNOTHERAPY, 1996, 19 (05) :364-374
[9]  
Fisher RI, 1997, CANCER J SCI AM, V3, pS70
[10]   Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer [J].
Flanigan, RC ;
Salmon, SE ;
Blumenstein, BA ;
Bearman, SI ;
Roy, V ;
McGrath, PC ;
Caton, JR ;
Munshi, N ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1655-1659
123